Market Overview
The South Korea respiratory devices market represents a specialized segment of the country's USD 7.57 billion medical devices industry. As of 2025, the market is valued at USD 505.0 million, with regulatory oversight provided by the Ministry of Food and Drug Safety. The market serves a population with increasing rates of respiratory ailments, driven largely by demographic shifts and lifestyle factors common in developed East Asian economies.
- •Market valued at USD 505.0 million in 2025
- •Projected CAGR of 5.32% through 2034
- •Regulated by the Ministry of Food and Drug Safety (MFDS)
Growth Drivers
South Korea's rapidly aging demographic is the primary catalyst for market expansion, as older populations face elevated risks of chronic obstructive pulmonary disease, asthma, and sleep-related breathing disorders. The country's high healthcare expenditure per capita and advanced hospital infrastructure support adoption of sophisticated respiratory technologies. Additionally, rising pollution levels in major urban centers contribute to growing respiratory disease incidence.
- •Aging population driving demand for chronic respiratory management
- •High healthcare spending and advanced hospital infrastructure
- •Increasing air pollution contributing to respiratory disease prevalence
Segmentation and Regional Analysis
The market is segmented across ventilators, oxygen concentrators, and sleep apnea devices, each exhibiting distinct growth trajectories. Sleep apnea devices represent the fastest-growing segment at USD 142.26 million in 2025 with a 7.12% CAGR, reflecting heightened awareness of sleep disorders. Ventilators follow with a 6.8% CAGR through 2030, while oxygen concentrators grow more modestly at 3.7% over the same period.
- •Sleep apnea devices: USD 142.26 million in 2025, CAGR of 7.12% through 2035
- •Ventilators segment: projected CAGR of 6.8% through 2030
- •Oxygen concentrators segment: projected CAGR of 3.7% through 2030
Trends and Outlook
What are the recent trends and outlook?
The market is expected to benefit from technological integration, including portable and home-use respiratory devices, as healthcare shifts toward decentralized care models. Growing emphasis on preventive care and early diagnosis of respiratory conditions, particularly sleep apnea, is expanding the addressable patient population. The broader South Korean medical devices market growing at 7.5% CAGR suggests favorable conditions for respiratory device innovation and investment through the forecast period.
- •Increasing adoption of portable and home-use respiratory devices
- •Shift toward decentralized care models supporting home-based treatment
- •Technological innovation in connected and IoT-enabled respiratory monitoring devices
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.